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1 Abstract 
Concentration and retention of a rod-shaped virus during tangential flow 
ultrafiltration (UF) was assessed to evaluate the potential of membrane-based 
downstream methods with advantages such as easy scale-up for industrial 
processes. A recombinant baculovirus of the non-spherical Autographa 
californica M nucleopolyhedrovirus (AcMNPV), vHSGFP, expressing egfp was 
filtered using polyethersulfone membranes ranging from 30 to 1000 kDa 
molecular weight cut-off (MWCO). A 20-fold virus concentration was achieved 
when a membrane cut-off range of 100 to 1000 kDa was tested. Fouling was 
observed and cake formation and pore plugging were postulated as concurrent 
causes with different impact depending on the MWCO. A reduction of virus 
concentration in the range of 2 to 5 log units in the permeate was observed 
illustrating the potential of membrane-based virus filtration as a useful unit 
operation in downstream processing. 
2 Introduction 
Virus clearance is critical in pharmaceutical and biotechnological processes [1]. 
Downstream processing of viruses as products (e.g., viral vectors expressing 
genes for gene therapy) requires virus concentration and purification [2]. 
However, virus purification using sucrose or cesium chloride density 
centrifugation is time consuming and results in significant virus particle losses [2]. 
Pelleted viruses from centrifugation can be highly viscous and difficult to 
resuspend in solution [3]. Additionally, downstream processing of products 
possibly contaminated with viruses (e.g., human blood derived products and 
antibodies) requires suitable elimination steps regarding various viruses [3]. 
Therefore, evaluation and validation of alternative virus purification or virus 
removal methods such as UF are of interest since UF has advantages over other 
purification methods including low energy consumption, simplified scale-up, and 
no chemicals being introduced into the process [1].  
Virus removal and/or concentration have been reported for some viruses [2, 4, 5]. 
The logarithmic titer reduction is in the range of 1 to 8.5 [4] and using UF, 
oncoretroviral vectors were concentrated 16 to 25 times [2]. Though, at this time 
no standardized validation protocol for membrane-based virus filtration exists and 
processing properties are specific to individual virus formulations [3, 4]. Thus, 
filtration of viruses that are of industrial interest has to be characterized to assess 
process efficiency and product yield.  
AcMNPV has been widely used as foreign gene expression vector and was 
recently used to develop a vaccine against human papillomavirus [6]. The virus 
has attracted interest as a vector for gene therapy and is used as a potential 
insect biopesticide (e.g., as VPN80 [7] for cabbage and cotton cultivation). The 
rod-shaped budded virions (BV) (DNA genome, enveloped, 40 x 300 nm in size) 
of AcMNPV, a baculovirus pathogen for lepidopteran insects, are used in cell 
culture [8]. Previously a study in regard to BV storage at 4 °C, exposure to 
temperatures from 15 to 65 °C, and to shear stress through stirring and pumping 
was carried out [3]. The study presented here demonstrates the filtration behavior 
of a BV solution when filtration parameters with insignificant impact on virus 
infectivity or particle size are used. 
3 Materials and Methods 
Production of AcMNPV particles 
Cells of the IPLB-SF21-AE (SF-21) cell line (Invitrogen) adapted to Sf-900 II 
Serum Free Medium (SFM) (pH 6.1; 360 mOsmoles/kg; protein-free; a typical  
insect medium [9] containing mainly amino acids, glucose, CaCl2, MgCl2, KCl and 
MgSO4; Invitrogen) were grown at 27°C in SFM supplemented with 5 mg/l 
gentamicin (Invitrogen) and passaged twice weekly. The virus vHSGFP is a 
recombinant of AcMNPV that contains the egfp controlled by the Drosophila heat 
shock protein 70 (hsp70) promoter [10]. vHSGFP was grown in TC-100 medium 
(Invitrogen) supplemented with 10% FBS (Invitrogen) [3, 8].  
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Figure 1: BV cultivation for ultrafiltration purposes (motor, M). 
SF-21 cells were infected with vHSGFP in suspension culture at a multiplicity of 
infection (MOI) of 0.1 plaque forming units per cell (pfu/cell) [8]. BV in the 
supernatant was harvested 4 days post infection (p.i.) by centrifugation (1000 x g, 
10 min, at room temperature) and stored at 4 °C (Figure 1) [3, 8].  
Ultrafiltration and in-process detection 
A commercial ultrafiltration system (Sartoflow Slice 200 Benchtop, Sartorius) was 
used to concentrate BV solutions. Polyethersulfone (PES) flat sheet membranes 
(30, 50, 100 or 300 kDa molecular weight cut-off (MWCO), respectively, 0.1 μm 
pore size (which equates to about 1000 kDa, correlated using electron 
microscopy [11]); 19.5 x 4.5 cm effective filter area, Sartocon Slice 200, 
Sartorius) were flushed before usage with 100 ml water (purified with the Q-Gard 
2 Purification Pack, Millipore Co.; demineralized; not de-gassed; autoclaved). The 
trans membrane pressure (TMP) and the trans membrane flux were logged 
during processing (WinWedge® 32 software, Pressure Sensor Connection Box 
and TE4101 balance, Sartorius). The flow parallel to the membrane was set to 
150 ml/min [5, 12]. The feed vessel was equipped with BV solution (500 ml) and 
samples (from the feed and permeate each with 1ml) were collected at 100, 200, 
300, 400 and 450 ml (± 10 ml) of solution that passed the filter and were stored at 
4 °C in opaque containers. All filtration experiments were performed at room 
temperature (~ 25 °C) and in duplicate. Membranes were cleaned by back-
flushing with water from the permeate to the feed (10 min, 500 ml/min), then 
incubated for > 24 h at 50 °C in sodium hydroxide (1 mol/L, Fisher Scientific) and 
stored at 4 °C in a solution of sodium hydroxide (0.1 mol/L) with an addition of 20 
vol% ethanol (Aaper Alcohol Co.) [5]. The pseudo-steady state flux of water was 
detected as a benchmark before virus filtration experiments. The PSF was taken 
when the flux loss was less than 1 ml/min during 5 min or more.  Filtered BV 
solution was reused if no contamination and a viral titer ~ 5 x 106 pfu/ml ± 90% 
was present. 
Virus infectivity  
TCID50 endpoint dilution [8] based on the expression of the Green Fluorescent 
Protein by host cells infected with vHSGFP and an Eclipse TE200 microscope 
(green fluorescence emission filter, X200 magnification, Nikon) was utilized to 
assess the viral titer 5 days p.i. 
4 Results and Discussion 
The course of infectivity in the retentate during filtration with membranes ranging 
from 30 to 1000 kDa was determined using end-point dilution (Figure 2).  
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Figure 2: BV infectivity of retained solution versus the volume passing the 
membrane during filtration. The filtration system was equipped with 500 ml BV 
solution, operated at 150 ml/min volume flow parallel to the membrane and was 
stopped when 450 ml passed the membrane. Virus titer was determined by end-
point dilution. Filtrations were done in duplicate (black symbols indicate the first 
run, repetitions post cleaning are shown using white symbols). Solid lines are 
added for visualization.  
Considering the uncertainty of end-point dilution (0.5 log units [8]), the infectivity 
of BV solution retained using the 30 kDa membrane was constant. In a half-
logarithmic plot the course of infectivity using membranes ranging from 50 to 100 
kDa was linear and had a lower slope compared to the use of a higher MWCO. 
Infectivity increased gradually to about +1 log unit. This might be due to BV partly 
accumulated in a thin cake layer in front of the membrane. Opposing the 300 and 
1000 kDa filters, viral concentration values initially remained constant and then 
increased linear with a higher slope, slightly higher values of the final 
concentration and with increased repeatability. Thus, assumed clogging of these 
membrane pores by BV appears to occur at early times of filtration followed by 
exponential accumulation of BV in the retentate. High values of viral 
concentration of about 20 times were archived using 100 to 1000 kDa 
membranes. This is most likely due to a high ratio of particle average size to 
membrane pore size [3]. 
UF using the parameters described reduced infectivity in the range of 2 to 5 log 
units (Table 1). 
Viral titer (pfu/ml)MWCO (kDa)
1*                             2*
30
50
100
300
1000
(1.9 – 5.7) x 104                             L
(0.0 – 1.3) x 102 (2.4 – 6.9) x 104
L                  (0.1 – 3.2) x 102
(0.7 – 2.8) x 104 (1.3 – 6.9) x 102
(1.7 – 3.7) x 105 (0.7 – 1.2) x 105
A) were constant in the stated range. 
*) Concentrations in six samples were determined in two 
independent filtration experiments for each membrane.
L) Below  the limit of detection.
Table 1: Virus concentration in the permeateA
 
Values of the reduction were unordered and point presumably to the interaction 
between rod-shaped BV particles and the distribution of membrane pore size. 
Filtration of Aedes aegypti densonucleosisvirus (AeDNV) (spherical, 18 – 26 nm 
in size) decreased infectivity of permeate below the detection limit when a 
MWCO in the range of 30 to 100 kDa was used. Concurrently, protein 
concentrations were reported to increase from about 3 to 6 mg/ml in the retentate 
and to remain constant ~3 mg/ml in solution that passed through the membrane 
[5, 12]. Since the initial protein concentration was 30 fold higher than it was 
detected in this study (data not shown), various scenarios including aggregation 
and different fouling mechanisms, dependent on size and shape of membrane 
pores and viruses, may explain the retention of AeDNV as opposed by BV that 
passed membranes ranging from 30 to 100 kDa [13]. 
5 Conclusions 
AcMNPV is a baculovirus with broad applications [6, 7], including uses as a 
protein expression vector. However, the use of viruses for various applications is 
dependent on its purity and formulation. Membrane based virus filtration is widely 
used and advantageous in biotechnological and pharmaceutical downstream 
processing [12, 13], e.g., due to simplified scale-up [1]. 
In this study, BV of the baculovirus AcMNPV were successfully concentrated 20-
fold in a protein-free medium using UF with commercial flat-sheet PES 
membranes (100 to 1000 kDa MWCO) at an average TMP of 0.15 bar and ~25 
°C. Membrane-based filtration appears to be a feasible unit operation in 
downstream processing of BV for example for industrial scale protein expression. 
Using membranes and filtration parameters as determined here, our results 
suggest that reduction of BV in filtered solutions to below detection limits can not 
be guaranteed using the protocol and the membranes tested here. However, 
filtration in the tested MWCO range led to reproducible reduction of BV 
concentration in the permeate by 2 to 5 log units compared to the unfiltered feed.  
Hence, membrane-based virus clearance from solutions is beneficial as a unit 
operation in biotechnological downstream processing since multi-step procedures 
are generally needed and membrane filtration can significantly reduce the 
presence of virus as an initial step to facilitate further processing. 
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